Skip to content

Effectiveness of a Public Campaign to Increase Stroke Awareness in Reducing Prehospital Delay

Cluster Randomized Controlled Trial to Assess the Effectiveness of a Population-based Educational Campaign on Stroke Symptom Recognition in Reducing Pre-hospital Delay

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01881152
Enrollment
1772
Registered
2013-06-19
Start date
2013-06-30
Completion date
2014-12-31
Last updated
2015-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke

Keywords

Stroke, Community education, Awareness, Prehospital delay

Brief summary

The starting hypothesis is that a multilevel educational campaign, specifically developed for the local community, can increase public stroke awareness and reduce pre-hospital delay. The effectiveness of such intervention will be evaluated according to a cluster randomized, stepped wedged design. The clusters are the four communities of the Area Vasta Emilia Nord, AVEN (Parma, Piacenza, Modena e Reggio Emilia). As analysis Units, we will consider the patients consecutively admitted to the six participating hospitals throughout the study period, for suspected stroke or transitory ischemic attack (TIA).

Detailed description

After a baseline 3 month period, the educational campaign will be sequentially launched in the four communities over four 3 month periods, according to a computer-generated list. The comparison will be theusual care. Primary outcome measures: The proportion of patients arriving at the Emergency Department (ED) with suspected stroke or TIA within two hours. Secondary outcome measures: the proportion of patients with confirmed stroke or TIA diagnosis; the proportion of ischemic stroke patients evaluated for recominanat Tissue Plasminogen Activator (rTPA) therapy; the proportion of patients treated with rTPA; time interval between arrival at the ED and CT scan; for patients treated with rTPA, time interval between arrival at the ED and therapy initiation (door to needle time); death and disability (assessed as modified Rankin Score 3-5) at 1 and 3 month from stroke onset.

Interventions

Multilevel educational campaign on stroke sympton recognition and the need for calling the Emergency Services

OTHERUsual care

Information on stroke usually delivered at the community level.

Sponsors

Azienda Ospedaliero-Universitaria di Parma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients consecutively admitted to the six participating hospitals for suspected stroke or transitory ischemic attack (TIA), defined as abrupt onset of focal or generalized neurologic deficit of vascular origin.

Exclusion criteria

* No information available on the time of stroke onset. * No informed consent from patient or caregiver

Design outcomes

Primary

MeasureTime frameDescription
Percentage of early admissionTime interval from stroke onset to arrival at the Emergency DepartmentProportion of patients arriving to the Emergency Department with suspected stroke or TIA within two hours

Secondary

MeasureTime frameDescription
Poor outcome at 3 months3 months from stroke onsetDeath or disability (modified Rankin Scale 3-6) at 3 months
Rate of thrombolysisUp to 4 hours and 30 minutes from stroke onsetProportion of patients given thrombolysis
Poor outcome at 1 month1 month from stroke onsetDeath or disability (modified Rankin Scale 3-6)at 1 month
Delay in CT scanUp to 12 hours from admission at the EDTime interval between arrival at the Emergency Department and CT scan
Door to needle timeUp to 4 hours and 30 minutes from stroke onsetTime interval between arrival at the ED and thrombolysis initiation
Rate of thrombolysis activationUp to 3 hours from stroke onsetProportion of patients evaluated for thrombolysis

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026